EE05314B1 - Tiotroopiumsoola sisaldav inhaleeritav lahusekompositsioon - Google Patents

Tiotroopiumsoola sisaldav inhaleeritav lahusekompositsioon

Info

Publication number
EE05314B1
EE05314B1 EEP200300203A EEP200300203A EE05314B1 EE 05314 B1 EE05314 B1 EE 05314B1 EE P200300203 A EEP200300203 A EE P200300203A EE P200300203 A EEP200300203 A EE P200300203A EE 05314 B1 EE05314 B1 EE 05314B1
Authority
EE
Estonia
Prior art keywords
composition containing
solution composition
tiotropium salt
inhalable solution
inhalable
Prior art date
Application number
EEP200300203A
Other languages
English (en)
Estonian (et)
Inventor
Niklaus-Humke Barbara
Schmelzer Christel
Barth Petra
Drechsel Karin
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh & Co. Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co. Kg
Publication of EE200300203A publication Critical patent/EE200300203A/xx
Publication of EE05314B1 publication Critical patent/EE05314B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/537—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
EEP200300203A 2000-10-31 2001-10-24 Tiotroopiumsoola sisaldav inhaleeritav lahusekompositsioon EE05314B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10054036 2000-10-31
PCT/EP2001/012292 WO2002036104A2 (de) 2000-10-31 2001-10-24 Inhalative lösungsformulierung mit einem tiotropiumsalz

Publications (2)

Publication Number Publication Date
EE200300203A EE200300203A (et) 2003-10-15
EE05314B1 true EE05314B1 (et) 2010-08-16

Family

ID=7661723

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300203A EE05314B1 (et) 2000-10-31 2001-10-24 Tiotroopiumsoola sisaldav inhaleeritav lahusekompositsioon

Country Status (39)

Country Link
EP (2) EP1333819B1 (xx)
JP (1) JP4344135B2 (xx)
KR (1) KR100853107B1 (xx)
CN (2) CN100396285C (xx)
AR (1) AR038764A1 (xx)
AT (1) ATE373473T1 (xx)
AU (2) AU2002221738B2 (xx)
BG (1) BG66315B1 (xx)
BR (1) BRPI0115076B8 (xx)
CA (1) CA2426074C (xx)
CY (1) CY1107825T1 (xx)
CZ (1) CZ300794B6 (xx)
DE (2) DE50113037D1 (xx)
DK (1) DK1333819T3 (xx)
EA (1) EA007604B1 (xx)
EC (1) ECSP034541A (xx)
EE (1) EE05314B1 (xx)
ES (1) ES2294045T3 (xx)
HK (1) HK1060524A1 (xx)
HR (1) HRP20030338B1 (xx)
HU (1) HU229411B1 (xx)
IL (2) IL155538A0 (xx)
ME (1) ME00244B (xx)
MX (1) MXPA03003742A (xx)
MY (1) MY138940A (xx)
NO (1) NO332519B1 (xx)
NZ (1) NZ526023A (xx)
PE (1) PE20030092A1 (xx)
PL (1) PL203316B1 (xx)
PT (1) PT1333819E (xx)
RS (1) RS50859B (xx)
SA (1) SA01220482B1 (xx)
SI (1) SI1333819T1 (xx)
SK (1) SK286027B6 (xx)
TW (1) TWI293885B (xx)
UA (1) UA78690C2 (xx)
UY (1) UY26989A1 (xx)
WO (1) WO2002036104A2 (xx)
ZA (1) ZA200302922B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10216036A1 (de) * 2002-04-11 2003-10-23 Boehringer Ingelheim Pharma Aerosolformulierung für die Inhalation enthaltend ein Tiotropiumsalz
CN1292748C (zh) * 2003-03-05 2007-01-03 南昌弘益科技有限公司 噻托溴铵吸入粉雾剂及其制备工艺
PT1682541E (pt) * 2003-11-03 2010-04-14 Boehringer Ingelheim Int Processo para a preparação de sais de tiotrópio
PL2083007T3 (pl) * 2003-11-03 2013-09-30 Boehringer Ingelheim Int Sole tiotropium, sposoby ich wytwarzania oraz zawierające je kompozycje farmaceutyczne
EP1881980B1 (en) 2005-05-02 2012-08-22 Boehringer Ingelheim International GmbH Novel crystalline forms of tiotropium bromide
EP2044967A1 (de) * 2007-10-01 2009-04-08 Boehringer Ingelheim Pharma GmbH & Co. KG Zerstäuber
CN104306361A (zh) * 2014-09-24 2015-01-28 万特制药(海南)有限公司 一种含噻托溴铵的吸入性溶液
CN111374963A (zh) * 2018-12-31 2020-07-07 天津药业研究院有限公司 一种用于吸入的噻托铵溶液剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
SG45171A1 (en) * 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
DE19536902A1 (de) * 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
DE19847968A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen

Also Published As

Publication number Publication date
KR20030060926A (ko) 2003-07-16
ZA200302922B (en) 2004-04-22
ME00244B (me) 2011-05-10
EP1333819A2 (de) 2003-08-13
HUP0301378A3 (en) 2005-12-28
UA78690C2 (uk) 2007-04-25
AU2173802A (en) 2002-05-15
HRP20030338B1 (en) 2011-09-30
HUP0301378A2 (hu) 2003-10-28
BRPI0115076B1 (pt) 2016-07-26
YU33003A (sh) 2006-05-25
HRP20030338A2 (en) 2005-04-30
DE10152521A1 (de) 2002-07-11
SA01220482B1 (ar) 2007-07-31
ES2294045T3 (es) 2008-04-01
SK286027B6 (sk) 2008-01-07
ECSP034541A (es) 2003-05-26
DE50113037D1 (de) 2007-10-31
WO2002036104A2 (de) 2002-05-10
SI1333819T1 (sl) 2007-12-31
WO2002036104A3 (de) 2002-08-01
BR0115076A (pt) 2003-07-29
PL203316B1 (pl) 2009-09-30
PE20030092A1 (es) 2003-03-24
KR100853107B1 (ko) 2008-08-21
UY26989A1 (es) 2002-06-20
NZ526023A (en) 2005-05-27
MEP40408A (en) 2011-02-10
EP1837021A3 (de) 2008-03-19
CN100396285C (zh) 2008-06-25
CA2426074C (en) 2008-12-23
IL155538A0 (en) 2003-11-23
HU229411B1 (en) 2013-12-30
RS50859B (sr) 2010-08-31
NO20031911L (no) 2003-04-29
CZ300794B6 (cs) 2009-08-12
MY138940A (en) 2009-08-28
CY1107825T1 (el) 2013-06-19
SK5272003A3 (en) 2003-10-07
TWI293885B (en) 2008-03-01
BG107727A (bg) 2004-11-30
ATE373473T1 (de) 2007-10-15
CZ20031486A3 (cs) 2003-08-13
HK1060524A1 (en) 2004-08-13
NO332519B1 (no) 2012-10-08
JP4344135B2 (ja) 2009-10-14
EA007604B1 (ru) 2006-12-29
EE200300203A (et) 2003-10-15
MXPA03003742A (es) 2004-10-15
CN101292964A (zh) 2008-10-29
EP1333819B1 (de) 2007-09-19
IL155538A (en) 2008-11-26
EP1837021A2 (de) 2007-09-26
JP2004512357A (ja) 2004-04-22
PT1333819E (pt) 2007-10-29
DK1333819T3 (da) 2007-12-03
AR038764A1 (es) 2005-01-26
BRPI0115076B8 (pt) 2021-05-25
AU2002221738B2 (en) 2007-01-11
BG66315B1 (bg) 2013-04-30
PL360405A1 (en) 2004-09-06
NO20031911D0 (no) 2003-04-29
CA2426074A1 (en) 2002-05-10
CN1473038A (zh) 2004-02-04
EA200300482A1 (ru) 2003-12-25

Similar Documents

Publication Publication Date Title
DE60020343D1 (de) Cilostazol enthaltende zubereitung
ATE275391T1 (de) Neue tiotropium-haltige inhalationspulver
DE60135560D1 (de) Valsartan salze
NO20022922D0 (no) Inhalasjonsanordning
NO20042154L (no) Terapeutiske isokinolinforbindelser
NO20032909D0 (no) Glukopyranosyloksypyrazolderivater samt medikamentell anvendelse derav
NO20025450L (no) Ny farmasöytisk sammensetning
EE200200656A (et) Ravis kasutatavad tropaani derivaadid
ATE313952T1 (de) Stabile biozidale zusammensetzung
EE05020B1 (et) Glburiidi ravimkoostis
HK1129111A1 (en) Tiotropium salts, pharmaceutical formulations containing the salts and the use thereof
DK1299095T3 (da) Klart vandigt anæstetisk præparat
NO20022921D0 (no) Inhalasjonsanordning
ATE324883T1 (de) Pharmazeutische zusammensetzung enthaltend lumiracoxib
EE05343B1 (et) Tiotroopiumsoola sisaldav inhaleeritav lahusekompositsioon
ATE350016T1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
EE200300203A (et) Tiotroopiumsoola sisaldav inhaleeritav lahusekompositsioon
PT1227817E (pt) Composicao farmaceutica aquosa contendo ciclesonida
ATE338460T1 (de) Fungizide zusammensetzungen enthaltend fludioxonil
ATE297187T1 (de) Resorcinenthaltende zusammensetzung
DE60124516D1 (de) Kombination des lezithins mit ascorbinsäure
ATE350029T1 (de) Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain
IS6712A (is) Örmalað torsemíð
SE0004749D0 (sv) New salt form
SE9903847D0 (sv) Nicotine composition

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20101231